EXEVIR BIO
ExeVir Bio is a Belgium-based company that develops single-domain antibody-based therapies that help patients ward off viral infections. The company is harnessing a llama-derived antibody technology platform to generate robust antiviral therapies providing broad protection against coronaviruses. They using a highly innovative and clinically validated VHH technology to develop treatments for viral infections that may pose a significant global threat. ExeVir Bio develops a rapid response platfor... m for antivirals. This platform technology enables an agile response to new health threats thanks to its short throughput time to generate drug candidates. The resulting protein-based therapeutics are sufficiently stable and easy to produce at a reasonable cost to enable true global access. ExeVir Bio was founded in 2020 and is headquartered in Zwijnaarde, Belgium.
EXEVIR BIO
Social Links:
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2020-01-01
Address:
Zwijnaarde, Oost-Vlaanderen, Belgium
Country:
Belgium
Website Url:
http://www.exevir.com
Total Employee:
1+
Status:
Active
Contact:
750-495-334
Total Funding:
42 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Legendairy Foods
Formo is a cell-ag company that develops animal-free dairy products using nature-identical milk proteins from precision fermentation.
Current Advisors List
Current Employees Featured
Founder
Investors List
SFPI-FPIM
SFPI-FPIM investment in Series A - ExeVir Bio
Fund+
Fund+ investment in Series A - ExeVir Bio
Vives Louvain Technology Fund
Vives Louvain Technology Fund investment in Series A - ExeVir Bio
Meusinvest (Noshaq)
Meusinvest (Noshaq) investment in Series A - ExeVir Bio
Sambrinvest
Sambrinvest investment in Series A - ExeVir Bio
UCB Ventures
UCB Ventures investment in Series A - ExeVir Bio
V-Bio Ventures
V-Bio Ventures investment in Series A - ExeVir Bio
VIB
VIB investment in Series A - ExeVir Bio
S.R.I.W.
S.R.I.W. investment in Series A - ExeVir Bio
Official Site Inspections
http://www.exevir.com Semrush global rank: 4.5 M Semrush visits lastest month: 2.39 K
- Host name: 5.134.5.23.static.hosted.by.combell.com
- IP address: 5.134.5.23
- Location: Merelbeke Belgium
- Latitude: 51.0015
- Longitude: 3.7433
- Timezone: Europe/Brussels
- Postal: 9820